Wells Fargo’s Mateon Therapeutics, Inc. MATN Stock Holding History

Wells Fargo’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,500	Closed	-$3K	–	6648
2016 Q3	$3K	Hold	4,500	–	–	﹤0.01%	6022
2016 Q2	$3K	Buy	+4,500	New	+$3.19K	﹤0.01%	5923

Other funds holding MATN

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Wells Fargo's MATN Position: Q4 2016 in Review

Wells Fargo sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 4,500 shares — an estimated $3K sold.

Wells Fargo first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $3K in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

Wells Fargo reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Wells Fargo sold 4,500 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $3K.
Wells Fargo first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Wells Fargo's Mateon Therapeutics, Inc. position peaked at $3K in Q3 2016.
1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Wells Fargo's 13F filing for Q4 2016, filed 1 Feb 2017.